Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

venous insufficiency/seizures

Krækjan er vistuð á klemmuspjaldið
GreinarKlínískar rannsóknirEinkaleyfi
4 niðurstöður

[Efficacy of sulodexide in treatment of chronic venous insufficiency. Results of the ACCORD trial].

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
OBJECTIVE The purpose of our study was to evaluate both clinical and laboratory efficacy of sulodexide given at a daily dose of 500 lipasemic units (LSU) in patients presenting with class C3-C4 chronic venous insufficiency (CVI) according to the CEAP classification. METHODS The study included a

[Venous disorders associated with osteoarticular and rheumatoid diseases: therapeutic occurrence].

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The connections between venous disorders and osteoarticular or rheumatic diseases are common and varied, and it is important to know about therapeutic incidence. Several clinical patterns emerge from this interrelated pathology: --the point of interest in the venous symptoms of gout seems to be

Remote contralateral intraparenchymal hemorrhage after overdrainage of a chronic subdural hematoma.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND Chronic subdural hematoma (cSDH) is frequently seen by neurosurgeons. Treatment often includes evacuation of the subdural hematoma (SDH) through one or two burr holes and placement of a drain in the subdural space to further evacuate subdural fluid and prevent reaccumulation of blood

Transient global amnesia.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Transient global amnesia (TGA) is a clinical syndrome characterized by the sudden onset of anterograde amnesia (the inability to encode new memories), accompanied by repetitive questioning, sometimes with a retrograde component, lasting up to 24 hours, without compromise of other neurologic
Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge